{"id":11831,"date":"2018-10-25T09:19:43","date_gmt":"2018-10-25T13:19:43","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11831"},"modified":"2018-10-25T09:19:43","modified_gmt":"2018-10-25T13:19:43","slug":"hospital-owned-drug-company-doesnt-want-special-treatment-in-washington-exec-says","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11831","title":{"rendered":"Hospital-owned drug company doesn&#8217;t want special treatment in Washington, exec says"},"content":{"rendered":"<p>(By Alia Paavola for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>An executive of the new hospital-owned drug company Civica Rx said he and his partners are pleased with the response they&#8217;ve received from Capitol Hill regulators since a<a href=\"https:\/\/www.beckershospitalreview.com\/supply-chain\/9-things-to-know-about-the-hospital-owned-generic-drug-company.html\">nnouncing<\/a>\u00a0the formation of their nonprofit this fall, but they&#8217;re fine navigating things on their own. <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/hospital-owned-drug-company-doesn-t-want-special-treatment-in-washington-exec-says.html\">Continue reading article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10356\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills-300x225.jpg\" alt=\"\" width=\"300\" height=\"225\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills-300x225.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/05\/pills.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Alia Paavola for Becker&#8217;s Hospital Review) An executive of the new hospital-owned drug company Civica Rx said he and<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-11831","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11831"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11831\/revisions"}],"predecessor-version":[{"id":11832,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11831\/revisions\/11832"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}